Skip to main content
. 2010 Apr 9;138(3):674–681. doi: 10.1378/chest.10-0573

Figure 3.

Figure 3.

In subjects with chylous effusions, serum VEGF-D levels distinguish subjects with LAM from those with lymphangiomatosis. (A) Comparison of serum VEGF-D levels in subjects with S-LAM and history of chylous effusions vs women with lymphangiomatosis, a lymphatic disorder also associated with chylous effusions. Lines denote median values for each group. (B) ROC curve for LAM with chylous effusions vs lymphangiomatosis. The area under the ROC curve is 0.933 ± 0.051 (95% CI, 0.834-1.0). See Figure 1 legend for expansion of abbreviations.